CordovaCann (LVRLF) Stock Forecast & Price Target
LVRLF Analyst Ratings
There are no analyst ratings in the last 3 months.
LVRLF Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $0.01→$0.02 | hold | -40.90%Downside | Reiterated | 07/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $0.01→$0.02 | hold | -40.90%Downside | Reiterated | 07/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $0.01→$0.02 | sell | -40.90%Downside | Downgraded | 07/30/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | $0.01→$0.02 | sell | -43.36%Downside | Reiterated | 07/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $0.01→$0.02 | sell | -40.90%Downside | Downgraded | 07/30/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | $0.01→$0.02 | sell | -40.90%Downside | Reiterated | 07/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 07/30/26 | $0.01→$0.02 | hold | -40.90%Downside | Reiterated | TipRanks - PerPlexity | ||
| OpenAI - Gpt-5.6Sol | 07/30/26 | $0.01→$0.02 | hold | -40.90%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 07/30/26 | $0.01→$0.02 | sell | -40.90%Downside | Downgraded | TipRanks - DeepSeek | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 07/30/26 | $0.01→$0.02 | sell | -43.36%Downside | Reiterated | TipRanks - Anthropic | ||
| xAI - Grok-4.3 | 07/30/26 | $0.01→$0.02 | sell | -40.90%Downside | Downgraded | TipRanks - xAI | ||
| Google Drug Manufacturers - Specialty and Generic | 07/30/26 | $0.01→$0.02 | sell | -40.90%Downside | Reiterated | TipRanks - Google |
Best Analysts Covering CordovaCann
Copying Google Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -19.30% per trade.
Copying Google Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -19.30% per trade.
Copying Google Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -19.30% per trade.
LVRLF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, LVRLF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LVRLF average Analyst price target in the past 3 months is ―.
LVRLF Financial Forecast
LVRLF Sales Forecast
Next quarter’s sales forecast for LVRLF is $0 with a range of ― to ―. The previous quarter’s sales results were $2.16M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.